Evidence map›Paper›PMID 33888650›Full record

ArticleClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology2021

An Overview of Deep Learning Algorithms and Their Applications in Neuropsychiatry.

Gokhan Guney, Busra Ozgode Yigin, Necdet Guven, Yasemin Hosgoren Alici, Burcin Colak, Gamze Erzin, Gorkem Saygili

Abstract read
In one paragraph

Article in Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Deep Learning with Neuroimaging and Genomics in Alzheimer's Disease.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gokhan GuneyDepartment of Biomedical Engineering, Ankara University, Ankara, Turkey.ORCID https://orcid.org/0000-0003-0522-5877
Busra Ozgode YiginDepartment of Biomedical Engineering, Ankara University, Ankara, Turkey.ORCID https://orcid.org/0000-0003-4803-5504
Necdet GuvenDepartment of Biomedical Engineering, Ankara University, Ankara, Turkey.ORCID https://orcid.org/0000-0001-7181-7876
Yasemin Hosgoren AliciDepartment of Psychiatry, Baskent University, Ankara, Turkey.ORCID https://orcid.org/0000-0003-3384-8131
Burcin ColakDepartment of Psychiatry, Ankara University, Ankara, Turkey.ORCID https://orcid.org/0000-0002-1691-2886
Gamze ErzinDepartment of Psychiatry, Ankara Dışkapı Training and Research Hospital, Ankara, Turkey.ORCID https://orcid.org/0000-0001-8002-5053
Gorkem SaygiliDepartment of Biomedical Engineering, Ankara University, Ankara, Turkey.ORCID https://orcid.org/0000-0002-9049-2138

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deep learning (DL) algorithms have achieved important successes in data analysis tasks, thanks to their capability of revealing complex patterns in data. With the advance of new sensors, data storage, and processing hardware, DL algorithms start dominating various fields including neuropsychiatry. There are many types of DL algorithms for different data types from survey data to functional magnetic resonance imaging scans. Because of limitations in diagnosing, estimating prognosis and treatment response of neuropsychiatric disorders; DL algorithms are becoming promising approaches. In this review, we aim to summarize the most common DL algorithms and their applications in neuropsychiatry and also provide an overview to guide the researchers in choosing the proper DL architecture for their research.

Identifiers

PMID33888650
PMCPMC8077051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.